/CLINE-B.ST
CLINE-B.ST Stock - Cline Scientific AB (publ)
Healthcare|BiotechnologySTO
$0.07+0.00%
+$0.00 (+0.00%) • Aug 9
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.37
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.08
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CLINE-B.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.07 – $0.07
TARGET (TP)$0.08
STOP LOSS$0.06
RISK/REWARD1:1.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.37
52W High$0.18
52W Low$0.06
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $4.20M | $2.90M | $3,991 | $116,583 | $282,819 |
| Gross Profit | $4.10M | $5.72M | $2.86M | $2.48M | $2.55M |
| Gross Margin | 97.7% | 197.4% | 71650.0% | 2129.0% | 901.7% |
| Operating Income | $-3,108,861 | $-2,317,061 | $-3,503,694 | $-1,646,510 | $-1,780,623 |
| Net Income | $-3,147,972 | $-2,353,501 | $-3,569,862 | $-2,032,124 | $-2,413,351 |
| Net Margin | -75.0% | -81.2% | -89447.8% | -1743.1% | -853.3% |
| EPS | $-0.10 | $-0.10 | $-0.19 | $-0.11 | $-0.22 |
Company Overview
Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase. It has collaboration with AstraZeneca to utilize gradient technology. Cline Scientific AB (publ) was founded in 2012 and is based in Mölndal, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CLINE-B.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$0.00
Q4 2023
EPS Surprise History
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2024 | Apr 18, 2024 | — | — | — | — |
Q2 2024 | Apr 18, 2024 | — | — | — | — |
Q4 2023 | Dec 31, 2023 | — | $0.00 | — | — |
Q3 2023 | Sep 29, 2023 | — | $0.00 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.09 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.09 | — | — |
Q4 2022 | Dec 31, 2022 | — | $0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.01 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.13 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.08 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.00 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.10 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.10 | — | — |
Q4 2020 | Dec 31, 2020 | — | $0.07 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.08 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.11 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.10 | — | — |
Q4 2019 | Dec 31, 2019 | — | $0.05 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-0.08 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CLINE-B.ST
What is CLINE-B.ST's current stock price?
Cline Scientific AB (publ) (CLINE-B.ST) is currently trading at $0.07 per share. The stock has moved +0.00% today.
What is the analyst price target for CLINE-B.ST?
No analyst price targets are currently available for this stock.
What sector is Cline Scientific AB (publ) in?
Cline Scientific AB (publ) operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the STO exchange.
What is CLINE-B.ST's market cap?
Cline Scientific AB (publ) has a market capitalization of $0.00 billion, making it a small-cap company.
Does CLINE-B.ST pay dividends?
No, Cline Scientific AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorASAP.ST
Asarina Pharma AB (publ)
$0.03
Mkt Cap: $0.0B
BIOS.ST
Bioservo Technologies AB (publ)
$0.02
Mkt Cap: $0.0B
BONZUN.ST
Bonzun AB (publ)
$0.01
Mkt Cap: $0.0B
CYXO.ST
Cyxone AB (publ)
$0.02
Mkt Cap: $0.0B
DEAR.ST
Duearity AB (publ)
$0.02
Mkt Cap: $0.0B
IDOGEN.ST
Idogen AB (publ)
$0.12
Mkt Cap: $0.0B
PHARM.ST
Pharmiva AB (publ)
$0.56
Mkt Cap: $0.0B
REDW.ST
Redwood Pharma AB
$1.19
Mkt Cap: $0.0B
SCOL.ST
Scandion Oncology A/S
$0.00
Mkt Cap: $0.0B
ZICC.ST
Ziccum AB (publ)
$0.25
Mkt Cap: $0.0B
Explore stocks similar to CLINE-B.ST for comparison